The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Voliotis Dimitris since 2022.
This trader's CIK number is 1807910.
At the time of last reporting, Voliotis Dimitris was the SVP, Clinical Development of Zentalis Pharmaceuticals, Inc.. (stock ticker symbol ZNTL).
Also see all insider trading activities at Zentalis Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | ZNTL | 0 | $0 | 30,601 | $1,883,694 | 30,000 | $540,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-02-14 | ZNTL | Sale | 601 | 50.46 | 30,324 |
| 2022-01-20 | ZNTL | Sale | 10,000 | 60.86 | 608,620 |
| 2022-01-19 | ZNTL | Sale | 10,000 | 61.43 | 614,310 |
| 2022-01-18 | ZNTL | Sale | 10,000 | 63.04 | 630,440 |
| 2022-01-20 | ZNTL | Option Ex | 10,000 | 18.00 | 180,000 |
| 2022-01-19 | ZNTL | Option Ex | 10,000 | 18.00 | 180,000 |
| 2022-01-18 | ZNTL | Option Ex | 10,000 | 18.00 | 180,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Voliotis Dimitris (SVP, Clinical Development of Zentalis Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.